Fucoidan and galactooligosaccharides ameliorate high-fat diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism.

@article{Chen2019FucoidanAG,
  title={Fucoidan and galactooligosaccharides ameliorate high-fat diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism.},
  author={Qichao Chen and Min Liu and Pengyu Zhang and Shujun Fan and Jinli Huang and Shunying Yu and Caihua Zhang and Huajun Li},
  journal={Nutrition},
  year={2019},
  volume={65},
  pages={
          50-59
        }
}
  • Qichao Chen, Min Liu, +5 authors Huajun Li
  • Published in Nutrition 2019
  • Medicine
  • OBJECTIVES Dyslipidemia is an important risk factor for cardiovascular diseases. Fucoidan (FUC) is a polysaccharide extracted from brown marine algae with various biological activities. Galactooligosaccharides (GOS) are important prebiotics that exert benefits on the intestinal microbiota. The aim of this study was to investigate the effects of FUC and GOS on dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism. METHODS Twenty-four male inbred Sprague-Dawley (SD… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    3
    Twitter Mentions